IP Library Granted Patent US 10,374,036
Granted Patent B2
US 10,374,036 · App. 16/148,473 · Granted Aug 6, 2019

Food and beverage compositions infused with lipophilic active agents and methods of use thereof

Inventors: Michelle Reillo (Saint Augustine, FL); Marian E. Washington (Saint Augustine, FL)
H01L29/0673A23C9/156A23C9/16A23F3/405A23F5/28A23F5/465A23L2/52A23L3/44A23L27/84A23L29/035A23L29/25A23L33/10A23L33/105A23L33/115A23L33/15A61K9/0056A61K9/0095A61K9/148A61K31/05A61K31/167A61K31/192A61K31/196A61K31/352A61K31/355A61K31/405A61K31/455A61K31/465A61K31/5415A61K31/616A61K31/621A61K36/185A61K36/82A61K47/44A61K47/46B82Y10/00H01L21/02381H01L21/02461H01L21/02532H01L21/02603H01L21/823807H01L29/42376H01L29/42392H01L29/66439H01L29/66545H01L29/66795H01L29/775H01L29/785A23V2002/00H01L27/092
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,374,036
App. No.
16/148,473
Granted
Aug 6, 2019
Kind
B2
Abstract

Aspects described herein relate to food and beverage compositions infused with lipophilic active agents and methods of use for the treatment of a variety of disorders. More particularly, aspects described herein relate to food and beverage compositions infused with lipophilic active agents such as cannabinoids, nicotine, nonsteroidal anti-inflammatories (NSAIDs), and vitamins, that provide enhanced bioavailability of the lipophilic active agents in a subject, and that mask unpleasant tastes of lipophilic active agents.

Claims (25)

1. A process for making lipophilic active agent infused tea leaves, coffee beans, or cocoa powder comprising the steps of:

(i) contacting the tea leaves, coffee beans, or cocoa powder with an oil comprising the cannabinoid, the at least one additional lipophilic active agent, and the bioavailability enhancing agent; and

(ii) dehydrating the tea leaves, coffee beans, or cocoa powder; thereby producing the lipophilic active agent infused tea leaves, coffee beans, or cocoa powder;

wherein the lipophilic active agent infused tea leaves, coffee beans, or cocoa powder comprise a therapeutically effective amount of a cannabinoid and at least one additional lipophilic active agent, wherein the bioavailability enhancing agent comprises an edible oil comprising long chain fatty acids, wherein the bioavailability of the cannabinoid in a subject is at least 1.5 times greater than the bioavailability of the cannabinoid in the subject in the absence of the bioavailability enhancing agent, and further wherein the additional lipophilic active agent is selected from the group consisting of nicotine, a non-steroidal anti-inflammatory drug (NSAID), and a vitamin.

2. A process for making the lipophilic active agent infused tea leaves, coffee beans, or cocoa powder of claim 1 , wherein the bioavailability of the cannabinoid in a subject is at least 3 times greater than the bioavailability of the cannabinoid in the subject in the absence of the bioavailability enhancing agent.

3. A process for making the lipophilic active agent infused tea leaves, coffee beans, or cocoa powder of claim 1 , wherein the bioavailability of the cannabinoid in a subject is at least 4.5 times greater than the bioavailability of the cannabinoid in the subject in the absence of the bioavailability enhancing agent.

4. A process for making the lipophilic active agent infused tea leaves, coffee beans, or cocoa powder of claim 1 , wherein the bioavailability enhancing agent is free of omega-6 fatty acids.

5. A process for making the lipophilic active agent infused tea leaves, coffee beans, or cocoa powder of claim 1 , wherein the cannabinoid is a psychoactive cannabinoid.

6. A process for making the lipophilic active agent infused tea leaves, coffee beans, or cocoa powder of claim 1 , wherein the cannabinoid is a nonpsychoactive cannabinoid.

7. A process for making the lipophilic active agent infused tea leaves, coffee beans, or cocoa powder of claim 1 , wherein the bioavailability enhancing agent is a protective colloid, an edible oil or fat, and a cannabinoid taste masking agent.

8. A process for making the lipophilic active agent infused tea leaves, coffee beans, or cocoa powder of claim 1 , wherein the bioavailability enhancing agent is nonfat dry milk.

9. A process for making the lipophilic active agent infused tea leaves, coffee beans, or cocoa powder of claim 8 , further wherein the lipophilic active agent infused tea leaves, coffee beans, or cocoa powder are lyophilized.

10. A process for making a lipophilic active agent infused beverage product comprising the steps of:

(i) contacting tea leaves, coffee beans, or cocoa powder with an oil comprising a cannabinoid, an additional lipophilic active agent, and a bioavailability enhancing agent;

(ii) dehydrating the coffee beans or cocoa powder, thereby producing lipophilic active agent infused coffee beans or cocoa powder; and

(iii) steeping the lipophilic active agent infused tea leaves, coffee beans, or cocoa powder in a liquid, thereby producing the lipophilic active agent infused beverage product;

wherein the lipophilic active agent infused tea leaves, coffee beans, or cocoa powder comprise a therapeutically effective amount of the cannabinoid and the additional lipophilic active agent, wherein the bioavailability enhancing agent comprises an edible oil comprising long chain fatty acids, wherein the bioavailability of the cannabinoid in a subject is at least 1.5 times greater than the bioavailability of the cannabinoid in the subject in the absence of the bioavailability enhancing agent, and further wherein the additional lipophilic active agent is selected from the group consisting of nicotine, a non-steroidal anti-inflammatory drug (NSAID), and a vitamin.

11. A process for making the lipophilic active agent infused beverage product of claim 10 , wherein the bioavailability of the cannabinoid in a subject is at least 3 times greater than the bioavailability of the cannabinoid in the subject in the absence of the bioavailability enhancing agent.

12. A process for making the lipophilic active agent infused beverage product of claim 10 , wherein the bioavailability of the cannabinoid in a subject is at least 4.5 times greater than the bioavailability of the cannabinoid in the subject in the absence of the bioavailability enhancing agent.

13. A process for making the lipophilic active agent infused beverage product of claim 10 , wherein the bioavailability enhancing agent is free of omega-6 fatty acids.

14. A process for making the lipophilic active agent infused beverage product of claim 10 , wherein the cannabinoid is a psychoactive cannabinoid.

15. A process for making the lipophilic active agent infused beverage product of claim 10 , wherein the cannabinoid is a nonpsychoactive cannabinoid.

16. A process for making the lipophilic active agent infused beverage product of claim 10 , wherein the bioavailability enhancing agent is a protective colloid, an edible oil or fat, and a cannabinoid taste masking agent.

17. A process for making the lipophilic active agent infused beverage product of claim 10 , wherein the bioavailability enhancing agent is nonfat dry milk.

18. A process for making the lipophilic active agent infused beverage product of claim 10 , further wherein the lipophilic active agent infused tea leaves, coffee beans, or cocoa powder are lyophilized.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2020
From: DOCHERTY, JOHN; BUNKA, CHRISTOPHER ANDREW
To: POVIVA CORP.
Reel/Frame 052817/0805 →
Continuity (9)
Continuation 15952201 · Apr 12, 2018
Continuation 15808889 · Nov 10, 2017
Division 15225802 · Aug 1, 2016
Continuation 14735844 · Jun 10, 2015
Provisional Application 62161324 · May 14, 2015
Provisional Application 62153835 · Apr 28, 2015
Provisional Application 62037706 · Aug 15, 2014
Provisional Application 62010601 · Jun 11, 2014
Related Publication 20190035891A1 · Jan 31, 2019
Cited By (2)
US 12,194,018 US 12,225,913